Regeneron Pharmaceuticals (REGN) — Congressional trading
Health Care
Regeneron Pharmaceuticals (REGN) has 13 reported Congressional stock trading disclosures in our data, including 4 purchases and 9 sales among the most recent 13 (latest 2026-05-15).
Reported STOCK-Act stock transactions
| Trade date | Member | Type | Amount range | Filed | Source |
|---|---|---|---|---|---|
| 2026-05-15 | Hon. Gilbert Cisneros | Sale | $1,001 – $15,000 | 2026-06-08 | PTR |
| 2026-02-12 | Hon. Julia Letlow | Purchase | $1,001 – $15,000 | 2026-03-12 | PTR |
| 2025-11-18 | Hon. Gilbert Cisneros | Purchase | $1,001 – $15,000 | 2025-12-15 | PTR |
| 2025-05-15 | Hon. Rob Bresnahan | Purchase | $1,001 – $15,000 | 2025-06-09 | PTR |
| 2025-04-10 | Hon. Byron Donalds (spouse) | Sale | $1,001 – $15,000 | 2025-05-24 | PTR |
| 2025-04-10 | Hon. Byron Donalds | Sale | $1,001 – $15,000 | 2025-05-24 | PTR |
| 2025-04-08 | Hon. Rob Bresnahan | Sale | $1,001 – $15,000 | 2025-05-08 | PTR |
| 2025-04-07 | Hon. Jefferson Shreve | Sale | $15,001 – $50,000 | 2025-05-08 | PTR |
| 2025-04-01 | Hon. Julie Johnson (joint) | Sale | $1,001 – $15,000 | 2025-05-14 | PTR |
| 2025-02-25 | Hon. Rob Bresnahan | Sale | $1,001 – $15,000 | 2025-03-27 | PTR |
| 2025-02-12 | Hon. Julie Johnson (joint) | Sale | $1,001 – $15,000 | 2025-03-12 | PTR |
| 2025-01-24 | Hon. Josh Gottheimer (joint) | Sale | $1,001 – $15,000 | 2025-02-10 | PTR |
| 2025-01-15 | Hon. Julie Johnson (joint) | Purchase | $1,001 – $15,000 | 2025-02-12 | PTR |
Ask the chat about Congressional trading in REGN →
Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.
See the full company profile: Regeneron Pharmaceuticals (REGN).
Last updated 2026-05-15 (most recent disclosed transaction date).
Informational only — NOT financial advice. Congressional disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.